يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"А. И. Бабич"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Siberian journal of oncology; Том 23, № 1 (2024); 155-161 ; Сибирский онкологический журнал; Том 23, № 1 (2024); 155-161 ; 2312-3168 ; 1814-4861

    وصف الملف: application/pdf

    العلاقة: https://www.siboncoj.ru/jour/article/view/2968/1206Test; Поликарпов А.А., Таразов П.Г., Гранов Д.А., Полысалов В.Н. Рентгенэндоваскулярные процедуры в лечении больных с нерезектабельными метастазами колоректального рака в печени. Российский онкологический журнал. 2014; 19(4): 40–1.; Adam R., Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019; 3(1): 50–6. doi:10.1002/ags3.12227.; Tzeng C., Aloia T. Colorectal Liver Metastases. J Gastrointest Surg. 2012; 17: 195–201. doi:10.1007/s11605-012-2022-3.; Gruber-Rouh T., Naguib N., Eichler K., Ackermann H., Zangos S., Trojan J., Beeres M., Harth M., Schulz B., Nour-Eldin A., Vogl T.J. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: Long-term results over a 10-year period. Int J Cancer. 2013; 134: 1225–31. doi:10.1002/ijc.28443.; Alexander H.R., Bartlett D.L., Libutti S.K., Pingpank J.F., Fraker D.L., Royal R., Steinberg S.M., Helsabeck C.B., Beresneva T.H. Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal center. Ann Surg Oncol. 2009; 16(7): 1852–9. doi:10.1245/s10434-009-0482-9.; Ben-Shabat I., Hansson C.,Eilard M., Cahlin C., Rizell M., Lindnér P., Mattsson J., Bagge R. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma. J Vis Exp. 2015; (95): 52490. doi:10.3791/52490.; van Iersel L.B.J., Koopman M., van de Velde C.J.H., Mol L., van Persijn van Meerten E.L., Hartgrink H.H., Kuppen P.J.K., Vahrmeijer A.L., Nortier J.W.R., Tollenaar R.A.E.M., Punt C., Gelderblom H. Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy. Ann Oncol. 2010; 21(8): 1662–7. doi:10.1093/annonc/mdp589.; Hafström L.R., Holmberg S.B., Naredi P.L., Lindnér P.G., Bengtsson A., Tidebrant G., Scherstén T.S. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol. 1994; 3(2): 103–8. doi:10.1016/0960-7404(94)90005-1.; Huibers A., DePalo D.K., Perez M.C., Zager J.S., Olofsson Bagge R. Isolated hyperthermic perfusions for cutaneous melanoma in-transit metastasis of the limb and uveal melanoma metastasis to the liver. Clin Exp Metastasis. 2023. doi:10.1007/s10585-023-10234-6.; Olofsson Bagge R., Nelson A., Shafazand A., All-Eriksson C., Cahlin C., Elander N., Helgadottir H., Kiilgaard J.F., Kinhult S., Ljuslinder I., Mattsson J., Rizell M., Sternby Eilard M., Ullenhag G.J., Nilsson J.A., Ny L., Lindnér P. Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial). J Clin Oncol. 2023; 41(16): 3042–50. doi:10.1200/JCO.22.01705.; Bethlehem M.S., Katsarelias D., Olofsson Bagge R. Meta-Analysis of Isolated Hepatic Perfusion and Percutaneous Hepatic Perfusion as a Treatment for Uveal Melanoma Liver Metastases. Cancers (Basel). 2021; 13(18): 4726. doi:10.3390/cancers13184726.; Eggermont A.M., van IJken M.G., van Etten B., van der Sijp J.R., ten Hagen T.L., Wiggers T., Oudkerk M., de Boeck G., de Bruijn E.A. Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure. Hepatogastroenterology. 2000; 47(33): 776–81.; Dewald C.L.A., Becker L.S., Maschke S.K., Meine T.C., Alten T.A., Kirstein M.M., Vogel A., Wacker F.K., Meyer B.C., Hinrichs J.B. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery. Clin Exp Metastasis. 2020; 37(6): 683–92. doi:10.1007/s10585-020-10057-9.; Vogel A., Ochsenreither S., Zager J.S., Wacker F., Saborowski A. Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidence. Cancer Treat Rev. 2023; 113: 102501. doi:10.1016/j.ctrv.2022.102501.; Rowcroft A., Loveday B.P.T., Thomson B.N.J., Banting S., Knowles B. Systematic review of liver directed therapy for uveal melanoma hepatic metastases. HPB (Oxford). 2020; 22(4): 497–505. doi:10.1016/j.hpb.2019.11.002.; https://www.siboncoj.ru/jour/article/view/2968Test

  2. 2
    دورية أكاديمية

    المصدر: Pelvic Surgery and Oncology; Том 8, № 4 (2018); 60-64 ; Тазовая хирургия и онкология; Том 8, № 4 (2018); 60-64 ; 2686-7435 ; 10.17650/2220-3478-2018-8-4

    وصف الملف: application/pdf

    العلاقة: https://ok.abvpress.ru/jour/article/view/267/227Test; Hemandas A.K., Abdelrahman T., Flashman K.G. et al. Laparoscopic colorectal surgery produces better outcomes for high risk cancer patients compared to open surgery. Ann Surg 2010;252(1):84—9. PMID: 20562603. DOI:10.1097/SLA.0b013e3181e45b66.; Mahmoud A.M., Moneer M.M. Toward standardization of laparoscopic resection for colorectal cancer in developing: a step by step module. J Egypt Nati Canc Incs 2017;29(3):135—40. PMID: 28668495. DOI:10.1016/j.jnci.2017.04.003.; Guillou PJ., Quirke P., Thorpe H. et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicenter, randomized controlled trial. Lancet 2005;365(9472):1718—26. PMID: 15894098. DOI:10.1016/S0140-6736(05)66545-2.; Jeong S.Y., Park J.W., Nam B.H. et al. Open versus laparoscopic surgery for midrectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, noninferiority, randomised controlled trial. Lancet Oncol 2014;15(7):637-45. PMID: 24837215. DOI:10.1016/S1470-2045(14)70205-0.; Van der Pas M.H., Haglind E., Cuesta MA. et al. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomized, phase 3 trial. Lancet Oncol 2013;14(3):210—8. PMID: 23395398. DOI:10.1016/S1470-2045(13)70016-0.; Dincler S., Koller M.T., Steurer J. et al. Multidimensional analysis of learning curve in laparoscopic sigmoid resection: year results. Dis Colon Rectum 2003;46(10):1278—9.; Li J.C., Hon S.S., Ng S.S. et al. The learning curve for laparoscopic colectomy: experience of a surgical fellow in a university colorectal unit. Surg Endosc 2009;23(7):1603—8. PMID: 19452217. DOI:10.1007/s00464-0497-0.; Tsai K.Y., Kiu K.T., Huang M.T. et al. The learning curve for laparoscopic colectomy in colectomy cancer at a new regional hospital. Asian J Surg 2016;39(1):34—40. PMID: 25959025. DOI:10.1016/j.asjsur.2015.03.008.; Braga M., Vignali A., Gianotti L. et al. Laparoscopic versus open colorectal surgery: a randomized trial on short-term outcome. Ann Surg 2002;236(6):759—66. PMID: 12454514. DOI:10.1097/01.SLA.0000036269.60340.AE.; Balen-Rivera E., Suarez-Alecha J., Herrera-Cabezon J. et al. Training periods with experts improve results in colorectal laparoscopic surgery. Cir Esp 2010;87(1):13—9. PMID: 19726034. DOI:10.1016/j.cire-sp.2009.05.005.; Schlachta C.M., Mamazza J., Seshadri P.A. et al. Defining a learning curve for laparoscopic colorectal resection. Dis Colon Rectum 2001;44(2):217-22. PMID: 11227938.; Tekkis P.P., Senagore A.J., Delaney C.P., Fazio V.W. Evaluation of the learning curve in laparoscopic colorectal surgery: comparison of right-sided and left-sided resection. Ann Surg 2005;242(1):83-91. PMID: 15973105.; Leong S., Cahill R.A., Mehigan B.J., Stephens R.B. Considerations on the learning curve for laparoscopic colorectal surgery: a view from the bottom. Int J Colorectal Dis 2007;22(9):1109-15. PMID: 17404746. DOI:10.1007/s00384-007-0302-2.; https://ok.abvpress.ru/jour/article/view/267Test